FindTrial
Sign In

Phenobarbitone vs Levetiracetam in term asphyxiated babies.

To study the efficacy of levetiracetam in comparison to phenobarbitone as a first line anticonvulsant for neonatal seizures in asphyxiated term babies.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/05/025416
Enrollment
72
Registered
2020-05-28
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G931- Anoxic brain damage, not elsewhereclassified

Interventions

Intervention1: I just phenobarbitone vs ink levetiracetam for asphyxiated term babies: Phenobarbitone loading 20mg/kg f/b maintenance 5mg/kg/d Levetiracetam 20mg/kg loading f/b 10mg/kg/d Intervention2

Sponsors

Department of Neonatology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All term asphyxiated babies born at our tertiary centre who satisfy WHO definition of asphyxia with seizures within 48 hours of life

Exclusion criteria

Exclusion criteria: Preterm Antenatal diagnosed cns malformation Metabolic seizures

Design outcomes

Primary

MeasureTime frame
Seizure control clinicallyTimepoint: 24 hours after loading dose—

Secondary

MeasureTime frame
Neurodevelopment at 12-18 months of ageTimepoint: 12-18 months—

Countries

India

Contacts

Public ContactDr Sukena Susnerwala

Gmc Aurangabad

deshmukhls@yahoo.com9822478275

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026